Stockreport

Sionna Therapeutics Reports Third Quarter 2025 Financial Results [Yahoo! Finance]

Sionna Therapeutics, Inc.  (SION) 
PDF Successfully completed drug-drug interaction study to support initiation of PreciSION CF Phase 2a Initiated Phase 1 trial evaluating NBD1 stabilizer SION-451 in propr [Read more]